49 results on '"Kletter, Kurt"'
Search Results
2. Logbuch für Klinische Praktika []
3. Konzepte des 3. Studienabschnitts im neuen Curriculum Humanmedizin an der Medizinischen Universität Wien []
4. PET based volume segmentation with emphasis on the iterative TrueX algorithm
5. Assessment of Regional Differences in Tariquidar-Induced P-Glycoprotein Modulation at the Human Blood–Brain Barrier
6. Aggression is Related to Frontal Serotonin-1A Receptor Distribution As Revealed by PET in Healthy Subjects
7. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the bodyʼs red cell volume
8. Pharmacoresistance in Epilepsy: A Pilot PET Study with the P-Glycoprotein Substrate R-[11C]verapamil
9. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients
10. Erste Ergebnisse der Entwicklung und Implementierung für eine strukturierte prägraduelle Lehre
11. Erste Ergebnisse einer Evaluationsstudie über eine Lehrveranstaltungsform im klinischen Unterricht
12. Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients
13. Imaging of Primitive Neuroectodermal Tumor (PNET) by Technetium-99m Tetrofosmin
14. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions
15. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects
16. A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET
17. Decreased blood-brain barrier P-glycoprotein function with aging
18. A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of 11C- and 14C-labelled verapamil in healthy volunteers
19. Abstract 2364: Chronic Heart Failure Leads to an Expanded Plasma Volume and Pseudoanemia, but Does Not Lead to a Reduction in the Body’s Red Cell Mass
20. Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood–Brain Barrier Studied with (R)-11C-Verapamil and PET
21. DHEAS and cortisol correlate with Hypothalamic Serotonin-1A Receptors
22. P-Glycoprotein inhibition at the blood-brain barrier visualized with (R)-[11C]verapamil μPET
23. Metabolism of (R)-[11C]verapamil in epilepsy patients
24. In vivo dose finding of tariquidar using (R)-[11C]verapamil μPET
25. [ 18 F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans
26. A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood-Brain Barrier with (R)-11C-Verapamil and PET.
27. Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood--Brain Barrier Studied with (R)-11C-Verapamil and PET.
28. Pharmacoresistance in Epilepsy: A Pilot PET Study with the P-Glycoprotein Substrate R-[11C]verapamil.
29. Typical Chest Pain and Normal Coronary Angiogram: Cardiac Risk Factor Analysis Versus PET for Detection of Microvascular Disease.
30. Gated Cardiac 13N-NH3 PET for Assessment of Left Ventricular Volumes, Mass, and Ejection Fraction: Comparison with Electrocardiography- Gated 18F-FDG PET.
31. Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans.
32. Electromechanical Properties of Perfusion/ Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET.
33. Imaging of Advanced Neuroendocrine Tumors with 18F-FDOPA PET.
34. Model-Based Analysis of Electrocardiography-Gated Cardiac 18F-FDG PET Images to Assess Left Ventricular Geometry and Contractile Function.
35. Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients.
36. Inhalation Scintigraphy with Iodine-123-Labeled Interferon Gamma-1b: Pulmonary Deposition and Dose Escalation Study in Healthy Volunteers.
37. Comparison of Iodine-123-Vasoactive Intestinal Peptide Receptor Scintigraphy and Indium-111-CYT-103 Immunoscintigraphy.
38. [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans
39. A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil
40. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects.
41. P-Glycoprotein inhibition at the blood-brain barrier visualized with (R)-[11C]verapamil µPET.
42. Metabolism of (R)-[11C]verapamil in epilepsy patients.
43. In vivo dose finding of tariquidar using (R)-[11C]verapamil µPET.
44. T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation.
45. Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis.
46. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
47. Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET.
48. Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
49. Model-based analysis of electrocardiography-gated cardiac (18)F-FDG PET images to assess left ventricular geometry and contractile function.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.